Your search for dronabinol returned 14 results
Drug Monograph
SYNDROS
Dronabinol 5mg/mL; oral soln; contains 50% w/w dehydrated alcohol, 5.5%w/w propylene glycol.
Drug News
Pill Form of Marijuana Found to Alleviate Pain for Longer Period
Dronabinol, a pharmaceutical formulation of the psychoactive component of marijuana, produces a longer duration of pain relief than smoked marijuana.
News
Dronabinol Oral Solution Approved by FDA
The FDA has approved Syndros (dronabinol oral solution) for the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
News
DEA Designates Syndros as Schedule II Drug
Syndros is anticipated to launch in the second half of 2017. It will be available as a 5mg/mL strength oral solution.
News
Old Anti-Nausea Agent May Be Effective for Sleep Apnea
"Expanded and pivotal clinical trials must still be conducted to fully establish the best approach to cannabinoid therapy in obstructive sleep apnea," said lead author Professor David Carley.
News
FDA Approves Final Label for Syndros with CII Designation
Syndros is the first FDA-approved dronabinol solution for oral administration, containing the pharmaceutical version of tetrahydrocannabinol (THC).
News
Generic Marinol launched
Watson has launched a generic version of Solvay's Marinol (dronabinol capsules) in 2.5mg, 5mg, and 10mg dosage strengths.
News
AASM: Medical Marijuana Should Not Be Used to Treat Sleep Apnea
Continuous positive airway pressure (CPAP) remains the mainstay of medical treatment for OSA.
Features
Putting the Medical into Marijuana: Does Evidence Support Use?
Areas of potential medical use of THC include the relief of spasticity in neurodegenerative diseases, for pain reduction, and for seizure control.
